Diving and hyperbaric medicine最新文献

{"title":"Electroencephalographic (EEG) changes accompanying normal breathing of concentrated oxygen (hyperoxic ventilation) by healthy adults: a systematic review.","authors":"Lachlan D Barnes, Luke E Hallum, Xavier Ce Vrijdag","doi":"10.28920/dhm55.2.154-163","DOIUrl":"10.28920/dhm55.2.154-163","url":null,"abstract":"<p><strong>Introduction: </strong>Divers often increase their fraction of inspired oxygen (FIO₂) to decrease their risk of decompression sickness. However, breathing elevated pressures of oxygen can cause central nervous system oxygen toxicity (CNS-OT). This study aimed to review the literature describing the effect of hyperoxia on the electroencephalogram (EEG), thus exploring the potential for real-time detection of an impending CNS-OT seizure.</p><p><strong>Methods: </strong>We searched Medline, Embase, Scopus, and Web of Science for articles that reported EEG measures accompanying hyperoxic ventilation (FIO₂ = 1.0 ± hyperbaric pressure) in healthy participants. We included peer-reviewed journal articles, books, and government reports with no language or date restrictions. Randomised controlled trials and cross-over studies were included; case reports were excluded. We used the Newcastle-Ottawa scale to evaluate evidence quality.</p><p><strong>Results: </strong>Our search strategy returned 1,025 unique abstracts; we analysed the full text of 46 articles; 22 articles (16 studies) were included for review. Study cohorts were typically small and comprised of male non-divers. We discovered a variety of EEG analysis methods: studies performed spectral analysis (n = 12), the analysis of sensory-evoked potentials (n = 4), connectivity/complexity analysis (n = 3), source localisation (n = 1), and expert qualitative analyses (n = 4). Studies of severe exposures (long duration at hyperbaric pressure) typically reported qualitative measures, and studies of mild exposures typically reported quantitative measures.</p><p><strong>Conclusions: </strong>There is a need for a large randomised controlled trial reporting quantitative measures to better understand the effect of hyperoxia on the EEG, thus enabling the development of real-time monitoring of CNS-OT risk.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"154-163"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and efficacy of continuous glucose monitoring devices in individuals with diabetes undergoing hyperbaric oxygen therapy: a scoping review.","authors":"Glen Katsnelson, Marcus Salvatori, George Djaiani, Elise Greer, Jordan Tarshis, Rita Katznelson","doi":"10.28920/dhm55.2.164-172","DOIUrl":"10.28920/dhm55.2.164-172","url":null,"abstract":"<p><strong>Introduction: </strong>Continuous glucose monitoring devices (CGMs) have emerged as an effective approach to optimise glycaemic control for individuals living with diabetes mellitus. Despite CGMs offering improved patient satisfaction and quality of life, they have been primarily validated for outpatient and home use. This has posed a challenge for patients and providers who wish to incorporate CGMs into clinical settings such as hyperbaric oxygen therapy (HBOT). Those with advanced diabetes mellitus who have diabetic foot ulcers that are refractory to treatment are among the most prevalent users of HBOT. However, those who prefer to use their CGM during HBOT face uncertainty regarding the accuracy and safety of their device under hyperbaric conditions.</p><p><strong>Methods: </strong>The product specifications of commonly used CGMs were collated. In addition, a scoping review of the literature was conducted where Medline, Embase, and Scopus were searched for reports that assess the accuracy or safety of CGMs in hyperbaric conditions.</p><p><strong>Results: </strong>The product specifications of commonly used CGMs by Dexcom, Abbott, Medtronic, and Senseonics demonstrate a maximum validated pressure of approximately 106 kPa (1.06 atmospheres absolute). Our literature search identified five reports, of which four focused on accuracy and one focused on safety of CGMs in hyperbaric conditions. Treatments were conducted in multiplace chambers and cumulatively described 39 participants, of whom 12 have diabetes. Although heterogeneous in nature, the reports generally supported the safety and accuracy of CGMs in hyperbaric conditions.</p><p><strong>Conclusions: </strong>The safety and accuracy of using CGMs during HBOT warrants further investigation. CGMs have not been validated for repeated exposure to hyperbaric conditions and should not be used in oxygen pressurised monoplace chambers until further safety data is available. We provide practical recommendations for use of CGMs in multiplace chambers.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"164-172"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diving practices in technical divers' community and behaviour towards self-reported unusual symptoms.","authors":"Emmanuel Gouin, David Pm Monnot, Thierry Michot, François Guerrero, Jean-Éric Blatteau","doi":"10.28920/dhm55.2.114-125","DOIUrl":"10.28920/dhm55.2.114-125","url":null,"abstract":"<p><strong>Introduction: </strong>The use of gas mixtures containing helium for deep recreational diving is increasingly common, involving complex logistics and decision-making compromises. The characteristics and inherent risks of this practice remain poorly documented. This study aims to provide an epidemiological inventory of practices and diving-related incidents within the technical diving community.</p><p><strong>Methods: </strong>An international online survey was disseminated on social networks targeting certified trimix divers. It collected demographic data, diving experience, and dive management practices, along with self-reported unusual symptoms, treatments, and outcomes following trimix dives.</p><p><strong>Results: </strong>A total of 558 questionnaires were analysed, predominantly from males (92%), mostly over 46 years old (61%), with high certification levels and recreational diving purposes. Forty-two percent reported one or more medical risk factors related to diving. Rebreather use was prevalent (79% at least occasionally). Decompression was primarily managed using compartmental models (85%) with gradient-factors adjustment. Dive planning varied significantly among individuals. Gas density at depth frequently exceeded the current recommendations. Ten percent had experienced symptoms suggestive of gas toxicity, mainly related to nitrogen narcosis. Thirty-six percent (199/558) reported experiencing, at least once, symptoms of diving-related incidents, with 61% (n = 121/199) expressing certainty. In 48% (120/261) of incidents involving decompression sickness (DCS) or breathing symptoms, no treatment was initiated. Among episodes involving DCS symptoms (n = 254), 42% received normobaric oxygen, and 23% sought medical advice, while 16% were treated with hyperbaric oxygen. Only 2.5% reported probable long-lasting sequelae.</p><p><strong>Conclusions: </strong>The diversity of practices highlights the lack of robust scientific data supporting them. The accident rate in mixed-gas diving may be higher than in typical scuba air diving, though mostly of mild severity. Treatment appears to be neglected despite divers' high knowledge levels. Continued research into decompression and the physiological effects of these dives is essential, along with ongoing awareness and education efforts in diving first aid within this exposed community.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"114-125"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial.","authors":"Leen D'hoore, Peter Germonpré, Bert Rinia, Leonard Caeyers, Nancy Stevens, Costantino Balestra","doi":"10.28920/dhm55.2.104-113","DOIUrl":"10.28920/dhm55.2.104-113","url":null,"abstract":"<p><strong>Introduction: </strong>Long COVID syndrome is a major health issue. Multiple treatments have been proposed but efficacy is inadequately investigated. Hyperbaric oxygen therapy (HBOT) has been promoted based on a small number of publications. As there is potential for a placebo effect and the financial cost of HBOT is high, we sought to investigate the effects of HBOT in Long COVID in a randomised trial.</p><p><strong>Methods: </strong>We randomised 101 patients into four treatment groups, receiving 10 sessions of oxygen 'treatment' inside a pressure chamber, according to one of four modalities: A - 100% oxygen at 253 kPa (2.5 atmospheres absolute); B - 40% oxygen at 253 kPa; C - 100% oxygen at 101.3 kPa (1 atmosphere absolute); D - 21% oxygen at 101.3 kPa. Groups B and C thus received a similar effective oxygen dose of 101.3 kPa. Quality of life symptom scores (Visual Analogue Scale; EQ-5D-5L, C19-YRSm), a 6-minute walking test and five neurocognitive tests were administered before and after the treatment series. At three months post-treatment, a telephone questionnaire probed for lasting effects.</p><p><strong>Results: </strong>All groups were comparable with regards to demographics, Long COVID symptoms and severity. After treatment, there were no significant differences in subjective symptoms, functional scores, and cognitive performance between any groups. The response to treatment was highly variable, with some patients in even the 'placebo' group D reporting a significant improvement in their well-being. This was not reflected in any objective outcome scores. No subgroups of patients responded better to any of the treatments.</p><p><strong>Conclusions: </strong>There was no significant effect from different doses of oxygen in a hyperbaric chamber. It is possible that the very modest improvements reported in other studies were due to a placebo effect. Claims that HBOT has a significant effect on Long COVID need further investigation before indiscriminately prescribing or promoting HBOT.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"104-113"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of three infusion pumps as an option for intensive care treatments in monoplace hyperbaric chambers.","authors":"Gerald Schmitz","doi":"10.28920/dhm55.2.145-153","DOIUrl":"10.28920/dhm55.2.145-153","url":null,"abstract":"<p><strong>Introduction: </strong>Hyperbaric oxygen therapy (HBOT) is used in critical care for managing certain severe conditions. However, the reliability of infusion pumps under hyperbaric conditions remains a critical concern. This study evaluated the performance of three infusion pump models - the Mindray BeneFusion VP5, Baxter Flo-Gard 6201, and Braun Infusomat Space - under hyperbaric conditions.</p><p><strong>Methods: </strong>Infusion pumps were modified to deliver flow into an environment pressurised up to 284 kPa. Accuracy of flow delivered into a pressurised monoplace chamber were tested across a range of infusion rates (1-100 mL·h⁻¹), with different absolute chamber pressures during the iso-pressure phase (243-284 kPa) and a range of different pressurisation/decompression rates (6.9-34.5 kPa·min⁻¹).</p><p><strong>Results: </strong>More than 3.6 million measurements were obtained. At iso-pressure the Mindray BeneFusion VP5 and the Baxter Flo-Gard 6201 under-performed at low infusion rates (< 20 mL·h⁻¹) and over-performed at high infusion rates (> 20 mL·h⁻¹). Both models exhibited significant under-delivery during pressurisation and over-delivery during decompression. For all conditions the Mindray BeneFusion VP5 demonstrated superior performance. The Braun Infusomat Space was unsuitable for hyperbaric use, failing to maintain performance at pressures above 90 kPa.</p><p><strong>Conclusions: </strong>The Mindray BeneFusion VP5 outperformed the Baxter Flo-Gard 6201 and Braun Infusomat Space under hyperbaric conditions, offering enhanced reliability for critical care HBOT using monoplace chambers. Clinical protocols should prioritise pumps capable of maintaining flow accuracy during pressure fluctuations. These findings inform best practices for infusion pump use in hyperbaric intensive care, addressing a critical gap in HBOT safety and efficacy.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"145-153"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An unblinded training exposure to hypoxia enhances subsequent hypoxia awareness.","authors":"August Allocco, Hanna van Waart, Charlotte Jw Connell, Nicole Ye Wong, Abhi Charukonda, Nicholas Gant, Xavier Ce Vrijdag, Simon J Mitchell","doi":"10.28920/dhm55.2.136-144","DOIUrl":"10.28920/dhm55.2.136-144","url":null,"abstract":"<p><strong>Introduction: </strong>Malfunctions and human errors in diving rebreathers can cause hypoxia, hyperoxia, and/or hypercapnia. We evaluated whether a prior unblinded hypoxia experience enhances a diver's ability to recognise hypoxia and initiate self-rescue.</p><p><strong>Methods: </strong>Forty participants were randomised to receive either an information leaflet describing hypoxia symptoms or an unblinded hypoxia experience, prior to a blinded hypoxia testing exposure during a virtual reality dive over one month later. The primary outcome was the comparison of the proportion of participants in these two groups who initiated self-rescue before reaching a peripheral oxygen saturation of 70% in the blinded exposure. An individual's 'symptom profile' was assessed by comparing symptoms during the unblinded hypoxia experience and blinded testing exposures.</p><p><strong>Results: </strong>During the blinded hypoxia testing exposure, 18/20 (90%) participants in the hypoxia experience group performed a self-initiated rescue compared to 6/18 (33%) in the information leaflet group (P < 0.001). Participants in the information leaflet group had lower mean SpO₂ (73.4% vs 81.4%, mean difference 8% [95% CI = 2.5-13.5%, P = 0.005]) and lower inhaled oxygen fraction (7.6% vs 9.4%, mean difference 1.8% [95% CI = 0.6-3.1%, P = 0.005]) at self-rescue. The most frequent and severe symptoms were light-headedness and shortness of breath. Of the 20 participants completing both hypoxia exposures, 14 (70%) had a consistent hypoxia symptom profile, which was not related to the ability to recognise hypoxia.</p><p><strong>Conclusions: </strong>Self-rescue was approximately three times more likely for participants who had previously experienced hypoxia compared to simply receiving information on relevant symptoms. Most participants exhibited a consistent pattern of individual symptoms, which did not result in earlier or improved detection of hypoxia.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"136-144"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Core outcome set for research in necrotising soft tissue infection patients: an international, multidisciplinary, modified Delphi consensus study.","authors":"Bridget Devaney, Jonathan Pc Wackett, Nicola Ma, Amanda Nguyen, Vikash Yogaraj, Morten Hedetoft, Ole Hyldegaard, Aidan Burrell, Biswadev Mitra","doi":"10.28920/dhm55.2.91-103","DOIUrl":"10.28920/dhm55.2.91-103","url":null,"abstract":"<p><strong>Introduction: </strong>Necrotising soft tissue infections (NSTI) are serious infections associated with considerable morbidity and mortality. Heterogeneity of outcome reporting in the NSTI literature precludes the synthesis of high-quality evidence. There is substantial interest in studying the efficacy of hyperbaric oxygen treatment as an adjunctive treatment in NSTI. The aim of this study was to develop a set of core outcome measures for future trials evaluating interventions for NSTI.</p><p><strong>Methods: </strong>A modified Delphi consensus method was used to conduct a three-round survey of a diverse panel of clinicians and researchers with expertise in NSTI, and patients with lived experience of NSTI. Participants rated the preliminary list of outcomes using a 9-point scale from 1 (least important) to 9 (most critical). The a priori definition of consensus required outcomes to be rated critical (score ≥ 7) by ≥ 70% of participants, and not important (score ≤ 3) by ≤ 15% of participants. After meeting consensus, outcomes were removed from subsequent rounds. Outcomes that did not meet consensus were included in subsequent rounds.</p><p><strong>Results: </strong>Ninety-eight participants from 14 countries registered and 86%, 69% and 57% responded for each round, respectively. Outcome measures quantifying five core areas achieved consensus: Death, surgical procedures of debridements and amputations, functional outcome among survivors, measures of sepsis, including septic shock and organ dysfunction and resource use measured through length of hospital and intensive care unit stay.</p><p><strong>Conclusions: </strong>This initial core set of outcome measures will be evaluated and optimised and can harmonise outcome measurements for investigations among patients with NSTI.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"91-103"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144339955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extremely deep bounce dives: planning and physiological challenges based on the experiences of a sample of French-speaking technical divers.","authors":"Emmanuel Gouin, Emmanuel Dugrenot, Bernard Gardette","doi":"10.28920/dhm55.2.203-210","DOIUrl":"10.28920/dhm55.2.203-210","url":null,"abstract":"<p><strong>Introduction: </strong>Extreme deep technical diving presents significant physiological challenges. While procedures often blend elements from both recreational and commercial diving, many remain empirical and unvalidated for this purpose. The rise of closed-circuit rebreathers has reduced gas cost and logistical barriers, enabling more divers to reach unprecedented depths. This study, based on the experience of deep divers, explores the limits of extreme-depth diving and the strategies developed to overcome them.</p><p><strong>Methods: </strong>Eight rebreather divers (one female, seven males) with experience beyond 200 metres depth were interviewed regarding their preparation, planning, and execution of such dives. The dive profiles of their deepest dives were analysed.</p><p><strong>Results: </strong>All were highly experienced technical divers. The median maximal depth was 227 [209-302] metres, with a median total dive time of 290 [271-395] minutes. The gas density of the trimix mixture, oxygen exposure, and ascent rate consistently exceeded current recommendations. High pressure nervous syndrome did not appear to be a major limiting factor, whereas decompression posed greater challenges. Three divers experienced decompression sickness following their deepest dives, highlighting the uncertainty around decompression procedures.</p><p><strong>Conclusions: </strong>These dives require rigorous preparation, robust support systems, equipment modifications, and perfect skills to reduce risks, which remain excessively high. Data are lacking to validate current practices. Decompression procedures must be adapted for these demanding mixed-gas dives, which are inevitably prolonged. A dry underwater habitat could improve decompression tolerance. The role of hydrogen as a breathing gas remains uncertain and still needs to be clarified, but some consider it a promising avenue for further exploration.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 2","pages":"203-210"},"PeriodicalIF":0.8,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144340010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply - PFO and DCS of hyperbaric personnel.","authors":"Peter T Wilmshurst, Chris Edge","doi":"10.28920/dhm55.1.66","DOIUrl":"10.28920/dhm55.1.66","url":null,"abstract":"","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 1","pages":"66"},"PeriodicalIF":0.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dive Medicine Capability at Rothera Research Station (British Antarctic Survey), Adelaide Island, Antarctica.","authors":"Felix Nr Wood, Katie Bowen, Rosemary Hartley, Jonathon Stevenson, Matt Warner, Doug Watts","doi":"10.28920/dhm55.1.67","DOIUrl":"10.28920/dhm55.1.67","url":null,"abstract":"<p><p>In December, we published an article titled \"Dive Medicine Capability at Rothera Research Station (British Antarctic Survey), Adelaide Island, Antarctica\" by Wood FNR, Bowen K, Hartley R, et al. The corresponding author would like to include an additional author, as their contribution was significant but was inadvertently omitted in the initial online publication. While this correction has been made in several versions circulated by the journal, not all have been updated. As a result, we are issuing an errata. The title and abstract are as follows: (Wood FNR, Bowen K, Hartley R, Stevenson J, Warner M, Watts D. Dive medicine capability at Rothera Research Station (British Antarctic Survey), Adelaide Island, Antarctica. Diving and Hyperbaric Medicine. 2024 20 December;54(4):320-327. doi: 10.28920/dhm54.4.320-327. PMID: 39675740.) Rothera is a British Antarctic Survey research station located on Adelaide Island adjacent to the Antarctic Peninsula. Diving is vital to support a long-standing marine science programme but poses challenges due to the extreme and remote environment in which it is undertaken. We summarise the diving undertaken and describe the medical measures in place to mitigate the risk to divers. These include pre-deployment training in the management of emergency presentations and assessing fitness to dive, an on-site hyperbaric chamber and communication links to contact experts in the United Kingdom for remote advice. The organisation also has experience of evacuating patients, should this be required. These measures, as well as the significant infrastructure and logistical efforts to support them, enable high standards of medical care to be maintained to divers undertaking research on this most remote continent.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"55 1","pages":"67"},"PeriodicalIF":0.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}